Funder: Alzheimer's Drug Discovery Foundation
Due Dates: September 15, 2025 (Letter of Intent) | November 17, 2025 (Invited Full Proposal)
Funding Amounts: Up to $5,000,000 per award, multi-year duration, milestone-based payments focused on direct costs.
Summary: Supports IND-enabling studies and early-phase clinical trials for Alzheimer's and related dementias, prioritizing novel drug mechanisms related to aging biology and combination therapies.